Vanguard Group’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Hold |
|
|||||
|
2025
Q1 | $355K | Hold |
|
|||||
|
2024
Q4 | $570K | Hold |
|
|||||
|
2024
Q3 | $478K | Buy |
|
|||||
|
2024
Q2 | $471K | Sell |
|
|||||
|
2024
Q1 | $776K | Buy |
|
|||||
|
2023
Q4 | $163K | Buy |
|
|||||
|
2023
Q3 | $114K | Buy |
|
|||||
|
2023
Q2 | $48.8K | Hold |
|
|||||
|
2023
Q1 | $68.8K | Hold |
|
|||||
|
2022
Q4 | $103K | Buy |
|
|||||
|
2022
Q3 | $201K | Sell |
|
|||||
|
2022
Q2 | $266K | Hold |
|
|||||
|
2022
Q1 | $662K | Sell |
|
|||||
|
2021
Q4 | $2M | Sell |
|
|||||
|
2021
Q3 | $3.67M | Buy |
|
|||||
|
2021
Q2 | $3.45M | Sell |
|
|||||
|
2021
Q1 | $3.84M | Buy |
|
|||||
|
2020
Q4 | $3.69M | Buy |
|
|||||
|
2020
Q3 | $15.5M | Buy |
|
|||||
|
2020
Q2 | $23.4M | Buy |
|
|||||
|
2020
Q1 | $9.33M | Buy |
|
|||||
|
2019
Q4 | $12M | Buy |
|